Literature DB >> 9152697

Mood and symptom reporting among middle-aged women: the relationship between menopausal status, hormone replacement therapy, and exercise participation.

L Slaven1, C Lee.   

Abstract

Vasomotor, somatic, and psychological symptoms associated with menopause are often treated with hormone replacement therapy (HRT), but the role of nonpharmacological interventions has received little attention. Two studies used the Profile of Mood States (POMS) and Women's Health Questionnaire (WHQ) to examine the effects of exercise among 4 groups of Australian women: premenopausal, perimenopausal, postmenopausal without HRT, and postmenopausal with HRT. Study 1, a comparison of exercisers and nonexercisers, showed that exercisers' moods were significantly more positive than sedentary women's moods, regardless of menopausal state. Exercising women also scored lower on somatic symptoms and memory-concentration difficulties. Study 2 examined the acute effects of aerobic exercise (premenopausal, postmenopausal without HRT, and postmenopausal with HRT) and found significant enhancements in mood and reductions in reported somatic and vasomotor symptoms immediately following an aerobic class. Exercise may assist in the alleviation of some menopausal symptoms.

Entities:  

Mesh:

Year:  1997        PMID: 9152697     DOI: 10.1037//0278-6133.16.3.203

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  18 in total

1.  Validation of POMS questionnaire in postmenopausal women.

Authors:  Kathleen W Wyrwich; Holly Yu
Journal:  Qual Life Res       Date:  2011-01-29       Impact factor: 4.147

2.  Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation.

Authors:  Ellen B Gold; Alicia Colvin; Nancy Avis; Joyce Bromberger; Gail A Greendale; Lynda Powell; Barbara Sternfeld; Karen Matthews
Journal:  Am J Public Health       Date:  2006-05-30       Impact factor: 9.308

Review 3.  Physical activity and health during the menopausal transition.

Authors:  Barbara Sternfeld; Sheila Dugan
Journal:  Obstet Gynecol Clin North Am       Date:  2011-09       Impact factor: 2.844

4.  The impact of physical activity level on SF-36 role-physical and bodily pain indices in midlife women.

Authors:  Sheila A Dugan; Susan A Everson-Rose; Kelly Karavolos; Barbara Sternfeld; Deidre Wesley; Lynda H Powell
Journal:  J Phys Act Health       Date:  2009-01

5.  Differential association of modifiable health behaviors with hot flashes in perimenopausal and postmenopausal women.

Authors:  Erika Hyde Riley; Thomas S Inui; Ken Kleinman; Maureen T Connelly
Journal:  J Gen Intern Med       Date:  2004-07       Impact factor: 5.128

6.  Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study.

Authors:  Carolyn Gibson; Karen Matthews; Rebecca Thurston
Journal:  Fertil Steril       Date:  2014-02-01       Impact factor: 7.329

7.  Association between physical activity and depressive symptoms: midlife women in SWAN.

Authors:  Sheila A Dugan; Joyce T Bromberger; Eisuke Segawa; Elizabeth Avery; Barbara Sternfeld
Journal:  Med Sci Sports Exerc       Date:  2015-02       Impact factor: 5.411

8.  Effect of aerobic training on hot flushes and quality of life--a randomized controlled trial.

Authors:  Riitta Luoto; Jaana Moilanen; Reetta Heinonen; Tomi Mikkola; Jani Raitanen; Eija Tomas; Katriina Ojala; Kirsi Mansikkamäki; Clas-Håkan Nygård
Journal:  Ann Med       Date:  2011-06-03       Impact factor: 4.709

9.  Can depression be a menopause-associated risk?

Authors:  Claudio N Soares
Journal:  BMC Med       Date:  2010-12-01       Impact factor: 8.775

Review 10.  Estrogenic Plants: to Prevent Neurodegeneration and Memory Loss and Other Symptoms in Women After Menopause.

Authors:  Valentina Echeverria; Florencia Echeverria; George E Barreto; Javier Echeverría; Cristhian Mendoza
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.